324. Methylglutaconic aciduria Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 4 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 10
Methylglutaconic aciduria and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
324 | Methylglutaconic aciduria | - |
20 | Adrenoleukodystrophy | 1.000 |
94 | Primary sclerosing cholangitis | 1.000 |
160 | Congenital ichthyosis | 1.000 |
8 | Huntington disease | 1.000 |
265 | Lipodystrophy | 1.000 |
79 | Homozygous familial hypercholesterolemia | 1.000 |
93 | Primary biliary cholangitis | 1.000 |
296 | Biliary atresia | 1.000 |
316 | Carnitine cycle disorder | 1.000 |